Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database
- PMID: 16386668
- DOI: 10.1016/j.jacc.2005.09.022
Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database
Erratum in
- J Am Coll Cardiol. 2006 Apr 7;47(7):1502
Abstract
Approximately 50% of patients hospitalized for heart failure have preserved systolic function. These patients are more likely to be older, women, and hypertensive. Their duration of hospitalization is similar to that of heart failure patients with systolic dysfunction, but their in-hospital mortality risk is lower. This mortality risk is increased in the setting of renal insufficiency, and the two most important risk predictors are elevated blood urea nitrogen and systolic blood pressure < or = 125 mm Hg. Medical treatment strategies for patients with preserved systolic function are inconsistent and reflect the need for efficacious evidence-based treatment regimens.
Objectives: The aims of this analysis were to describe the clinical characteristics, management, and outcomes of patients hospitalized for acute decompensated heart failure (HF) with preserved systolic function (PSF).
Background: Clinically meaningful characteristics of these patients have not been fully studied in a large database.
Methods: Data from >100,000 hospitalizations from the Acute Decompensated Heart Failure National Registry (ADHERE) database were analyzed.
Results: Heart failure with PSF was present in 50.4% of patients with in-hospital assessment of left ventricular function. When compared with patients with systolic dysfunction, patients with PSF were more likely to be older, women, and hypertensive and less likely to have had a prior myocardial infarction or be receiving an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker. In-hospital mortality was lower in patients with PSF compared with patients with systolic dysfunction (2.8% vs. 3.9%; adjusted odds ratio [OR]: 0.86; p = 0.005), but duration of intensive care unit stay and total hospital length of stay were similar. Serum creatinine >2 mg/dl was associated with increased in-hospital mortality in both systolic function groups (PSF: 4.8%; systolic dysfunction: 8.4%; p < 0.0001), and the most powerful predictors of in-hospital mortality in both groups were blood urea nitrogen >37 mg/dl (OR: 2.53; 95% confidence interval [CI]: 2.22 to 2.87) and systolic blood pressure < or =125 mm Hg (OR: 2.58; 95% CI: 2.33 to 2.86).
Conclusions: Heart failure with PSF is common and is characterized by a unique patient profile. Event rates are worrisome and reflect a need for more effective management strategies.
Comment in
-
Examining the concept of preserved systolic function.J Am Coll Cardiol. 2006 Dec 19;48(12):2599-600. doi: 10.1016/j.jacc.2006.09.028. Epub 2006 Nov 22. J Am Coll Cardiol. 2006. PMID: 17174206 No abstract available.
Similar articles
-
Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.J Am Coll Cardiol. 2007 Aug 21;50(8):768-77. doi: 10.1016/j.jacc.2007.04.064. Epub 2007 Aug 6. J Am Coll Cardiol. 2007. PMID: 17707182
-
Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.J Am Coll Cardiol. 2007 May 15;49(19):1943-50. doi: 10.1016/j.jacc.2007.02.037. Epub 2007 Apr 30. J Am Coll Cardiol. 2007. PMID: 17498579
-
Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).J Card Fail. 2006 Mar;12(2):100-7. doi: 10.1016/j.cardfail.2005.09.005. J Card Fail. 2006. PMID: 16520256
-
Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis.J Am Coll Cardiol. 2004 Feb 4;43(3):317-27. doi: 10.1016/j.jacc.2003.07.046. J Am Coll Cardiol. 2004. PMID: 15013109 Review.
-
Treatment of heart failure with preserved systolic function.Arch Cardiovasc Dis. 2008 May;101(5):361-72. doi: 10.1016/j.acvd.2008.04.008. Epub 2008 Jul 7. Arch Cardiovasc Dis. 2008. PMID: 18656095 Review.
Cited by
-
Prognostic Factors for Survival at 6-Month Follow-up of Hospitalized Patients with Decompensated Congestive Heart Failure.ARYA Atheroscler. 2010 Fall;6(3):112-7. ARYA Atheroscler. 2010. PMID: 22577426 Free PMC article.
-
Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction.J Am Coll Cardiol. 2012 Mar 13;59(11):998-1005. doi: 10.1016/j.jacc.2011.11.040. J Am Coll Cardiol. 2012. PMID: 22402071 Free PMC article.
-
Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score.J Am Coll Cardiol. 2010 Mar 2;55(9):872-8. doi: 10.1016/j.jacc.2009.08.083. J Am Coll Cardiol. 2010. PMID: 20185037 Free PMC article. Clinical Trial.
-
Increased prevalence of concentric left ventricular hypertrophy in African-Americans: will an epidemic of heart failure follow?Heart Fail Rev. 2006 Dec;11(4):271-7. doi: 10.1007/s10741-006-0228-8. Heart Fail Rev. 2006. PMID: 17131073 Review.
-
Current Role of the CardioMEMS Device for Management of Patients with Heart Failure.Curr Cardiol Rep. 2019 Jul 27;21(9):98. doi: 10.1007/s11886-019-1194-9. Curr Cardiol Rep. 2019. PMID: 31352531 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous